Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Comparison of Serum Potassium Concentration, Antiarrhythmic Effect, and Myocardial Protective Effect Between Dexmedetomidine and Remifentanil Infusion in Patients Undergoing Coronary Artery Bypass Surgery

NCT01572454 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01572454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01572454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Comparison of Serum Potassium Concentration, Antiarrhythmic Effect, and Myocardial Protective Effect Between Dexmedetomidine and Remifentanil Infusion in Patients Undergoing Coronary Artery Bypass Surgery
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2012
Completion date
December 31, 2012
Enrollment
77 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrhythmia, coronary artery bypass graft, dexmedetomidine, hypokalemia, remifentanil